Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GUSB | P08236 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2822837 | 0.79 | — | — | |
| SCHEMBL9758981 | 0.74 | HPGD (0.31) | — | |
| SCHEMBL5961402 | 0.71 | — | — | |
| SCHEMBL7035231 | 0.70 | CYP3A4 (0.33) | — | |
| SCHEMBL276945 | 0.70 | ALDH1A1 (0.59) | — | |
| SCHEMBL4748430 | 0.68 | — | — | |
| SCHEMBL9705549 | 0.67 | — | — | |
| SCHEMBL31490802 | 0.65 | NUDT1 (0.62) | — | |
| SCHEMBL8408092 | 0.65 | — | — | |
| SCHEMBL239645 | 0.65 | NUDT1 (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119731159-A | SARS-CoV2 main proteinase inhibitor | 吉利德科学公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119604286-A | Methods for treating viral infections including SARS-COV-2 | 吉利德科学公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119031915-A | Methods and compositions for treating skin proliferative disorders and other skin conditions | 不对称疗法有限责任公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-118786128-A | Compounds and methods for treating viral infections | 吉利德科学公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-118766947-A | Methods for treating SARS CoV-2 infection | 吉利德科学公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-118662520-A | Methods for treating SARS CoV-2 infection | 吉利德科学公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-116660421-A | Method for dividing brain fatigue degree of healthy personnel in industrial production based on column chromatography | 中国民用航空总局第二研究所 | 2023-08-29 | — | — | CN | disclosed |
| CN-116648445-A | Methods for treating or preventing chronic kidney disease | 安索治疗公司 | 2023-08-25 | — | — | CN | disclosed |
| CN-116322759-A | Phospholipid compounds and uses thereof | 吉利德科学公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-2648675-A1 | HAIR RELAXING AND STRAIGHTENING COMPOSITIONS | International Flora Technologies, Ltd. (US) | 2013-10-16 | — | — | EP | disclosed |
| EP-0819753-A1 | Fuel additive | NIPPON OIL CO. LTD. (JP) | 1998-01-21 | — | — | EP | disclosed |
| US-5674887-A | Prevention of bone resorption | ELI LILLY AND COMPANY (US) | 1997-10-07 | — | — | US | disclosed |
| US-5658918-A | INHIBITING NASAL MUCOUS SECRETION | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1997-08-19 | — | — | US | disclosed |
| EP-0673938-A2 | Novel purine derivatives and pharmaceutically acceptable salts thereof | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1995-09-27 | — | — | EP | disclosed |
| CN-1108533-A | synergistic composition for treating skin | AWS SHAKIR MUSTAFA SALIM (GB) | 1995-09-20 | — | — | CN | disclosed |
| CN-1108532-A | Skin cancer treatment | AWS SHAKIR MUSTAFA SALIM (GB) | 1995-09-20 | — | — | CN | disclosed |
| CN-1108531-A | Gastrointestinal cancer treatment | AWS SHAKIR MUSTAFA SALIM (GB) | 1995-09-20 | — | — | CN | disclosed |
| US-5436258-A | Prevention of bone resorption | ELI LILLY AND COMPANY (US) | 1995-07-25 | — | — | US | disclosed |
| EP-0587378-A1 | Prevention of bone resorption | ELI LILLY AND COMPANY (US) | 1994-03-16 | — | — | EP | disclosed |
| US-4755391-A | Subjecting to low temperature water extraction followed by series of high temperature water extractions, removing filtrates, recovering cacao liquor | HERSHEY FOODS CORPORATION (US) | 1988-07-05 | — | — | US | disclosed |